Support | HZNP Message Board Posts


Horizon Pharma, Inc.

  HZNP website

HZNP   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  2100 of 2109  at  3/29/2022 6:56:11 PM  by

drugfree


Support

We are nearing the 200 sma at 102.90. Hope to see that level act as support. Frustrating to watch hznp drop while IBB rises. In an effort to keep it real, VRDN dosed their first subject in their trial of their next generation uricase with half life extension technology for subcutaneous dosing for TED patients. I took a small position as a hedge.

https://investors.viridiantherapeutics.com/news-releases/news-release-details/viridian-therapeutics-doses-first-subject-first-human-clinical


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 0  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board


Financial Market Data provided by
.
Loading...